[Donor- derived CD19 chimeric antigen receptor T cells for relapsed B cell malignancies after allogeneic hematopoietic stem cell transplantations]

Zhonghua Xue Ye Xue Za Zhi. 2016 Aug 14;37(8):725-8. doi: 10.3760/cma.j.issn.0253-2727.2016.08.021.
[Article in Chinese]
No abstract available